Your session is about to expire
← Back to Search
Duodenal Benzocaine Infusion for Diabetes
Study Summary
This trial will test if a new drug that reduces fat in the gut can help control blood sugar levels in people with diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You are between 30 and 55 years old.You have had surgery on your stomach, intestines, or pancreas before.Your body mass index (BMI) falls within the range of 19 to 27 kg/m2.You have had diarrhea, vomiting, or constipation in the past week.You have a history of digestive system diseases such as Crohn's disease, ulcerative colitis, celiac sprue, or Barrett's esophagus.You have a condition that makes it difficult or unsafe to insert a tube through your nose (such as a deviated septum, previous bleeding in the upper gastrointestinal tract, or a history of easy bleeding).
- Group 1: Benzocaine Infusion into Duodenum
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what conditions is Benzocaine Infusion into Duodenum a viable treatment option?
"The infusion of benzocaine into the duodenum is frequently used to alleviate laryngitis. It also has been demonstrated efficacious in treating sequelae caused by tonsillectomy, ulcers, and nausea-induced vomiting."
Are individuals aged 25 and older being welcomed to join the research project?
"This clinical trial seeks participants that are of legal age, but younger than 65 years old."
What is the upper threshold of participants for this trial?
"This trial has concluded its recruitment process, as the information was last updated on January 18th 2022. However, alternative studies are recruiting; 1 study is looking into lcfa's effect on nutrient absorption and 2 trials have opened for Benzocaine Infusion into Duodenum participants."
Are there reports of prior experiments using Benzocaine Infusion into the Duodenum?
"Presently, there are two distinct investigations into the efficacy of Benzocaine Infusion into Duodenum currently in progress. Neither have reached Phase 3 yet and most of them are situated in Nashville, Tennessee; however, research is also occurring at 2 other sites as well."
Has the FDA granted acceptance to infusing Benzocaine into the duodenum?
"This experimental intervention has only been subjected to a limited amount of safety testing, thus it was given an assessment of 1."
Does this research endeavor currently have any open enrollment?
"Unfortunately, this investigation is no longer recruiting participants. According to the information found on clinicaltrials.gov, it was initially posted in November 2012 and last modified in January 2022; however, there are 3 other trials actively enrolling patients presently."
Does my profile meet the criterion to be part of this research?
"To qualify for this medical trial, candidates must have lcfa-induced nutrient malabsorption and be of legal age (18 - 65). This clinical research is seeking to enrol a total of 20 participants."
Share this study with friends
Copy Link
Messenger